Trials / Completed
CompletedNCT02209012
Twelve Month Follow-Up of CP0108
Twelve Month Follow-Up Evaluation of Subjects Participating in DUSA-CP0108 (A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 206 (actual)
- Sponsor
- DUSA Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DUSA CP0108 study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aminolevulinic Acid (ALA) | Levulan PDT given in CP0108 |
| DRUG | Topical Solution Vehicle | Vehicle PDT given in CP0108 |
| DEVICE | BLU-U Blue Light Photodynamic Therapy Illuminator | PDT given in CP0108 |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-02-01
- Completion
- 2016-04-01
- First posted
- 2014-08-05
- Last updated
- 2016-09-23
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02209012. Inclusion in this directory is not an endorsement.